venetoclax,ibrutinib,rituximab
abbvie,janssen
['so proud']
so proud that our window 2 protocol for newly diagnosed mcl patients was presented by our dr. at the #icml2023 
Research Nurse Manager-Mantle Cell Lymphoma Clinical @ MD Anderson Cancer. Tweets are my own